Exhibit 10.22


 


SHAREHOLDER LOAN AGREEMENT


 


THIS SHAREHOLDER LOAN AGREEMENT (this “Agreement”)
dated this 16th day of January, 2018


 


BETWEEN:


 


Marc Duey of 2000 Art School Road, Chester Springs,
PA 19425


(the “Shareholder”)


 


OF THE FIRST PART


 


AND


 


Felicitex Therapeutics, Inc. of 27 Strathmore
Road, Natick, MA 01760


(the “Company”)


 


OF THE SECOND PART


 


IN CONSIDERATION OF the Shareholder lending
certain monies (the “Loan”) to the Company, and the Company repaying the Loan to the Shareholder, both parties agree to keep,
perform and fulfill the promises and conditions set out in this Agreement:


 


		1.	Loan Amount & Interest



 


The Shareholder promises to loan up to $550,000.00
USD to the Company and the Company promises to repay this principal amount to the Shareholder, with interest at 12%, payable on the unpaid
principal, upon demand.


 


		2.	Payment



 


This Loan is repayable within 15 day(s) of the
Shareholder providing the Company with written notice of demand.


 




     


     


    

 


		3.	Default



 


Notwithstanding anything to the contrary in this
Agreement, if the Company defaults in the performance of any obligation under this Agreement, then the Shareholder may declare the principal
amount owing and interest due under this Agreement at that time to be immediately due and payable.


 


		4.	Purpose



 


This Loan Agreement is intended to fund the Company
until such time an equity financing can be completed by the Company. The loan may be converted into common stock at the request of Shareholder
at a price per share equal to the price per share paid by Norma Investments on October 11, 2017 which is the last equity financing transaction
for the Company. The price paid by Norma Investments was $.25238 per share of common stock.


 


		5.	Governing Law



 


This Agreement will be construed in accordance
with and governed by the laws of the Commonwealth of Massachusetts.


 


		6.	Costs



 


All costs, expenses and expenditures including,
without limitation, the complete legal costs incurred by enforcing this Agreement as a result of any default by the Company, will be added
to the principal then outstanding and will immediately be paid by the Company.


 


		7.	Binding Effect



 


This Agreement will pass to the benefit of and
be binding upon the respective heirs, executors, administrators, successors and permitted assigns of the Company and Shareholder. The
Company waives presentment for payment, notice of non-payment, protest, and notice of protest.


 




    2


     


    

 


		8.	Amendments



 


This Agreement may only be amended or modified
by a written instrument executed by both the Company and the Shareholder.


 


		9.	Severability



 


The clauses and paragraphs contained in this Agreement
are intended to be read and construed independently of each other. If any term, covenant, condition or provision of this Agreement is
held by a court of competent jurisdiction to be invalid, void or unenforceable, it is the parties’ intent that such provision be reduced
in scope by the court only to the extent deemed necessary by that court to render the provision reasonable and enforceable and the remainder
of the provisions of this Agreement will in no way be affected, impaired or invalidated as a result.


 


		10.	General Provisions



 


Headings are inserted for the convenience of the
parties only and are not to be considered when interpreting this Agreement. Words in the singular mean and include the plural and vice
versa. Words in the masculine mean and include the feminine and vice versa.


 


		11.	Entire Agreement



 


This Agreement constitutes the entire agreement
between the parties and there are no further items or provisions, either oral or otherwise.


 




    3


     


    

 


IN WITNESS WHEREOF, the parties have duly
affixed their signatures under hand on this 16th day of January 2018.


  


	/s/ Marc Duey	 
	Marc Duey	 
	 	 
	 	 
	/s/ Maria Vilenchik	 
	Maria Vilenchik	 
	CEO	 
	Felicitex Therapeutics, Inc.	 


 


 


 


4